Newsbriefs

York Street Campus changes defibrillators/AEDs 

On Nov. 30, the York Street Campus standardized defibrillators/AEDs to Stryker LIFEPAK devices for adult patients. All adult inpatient and adult Emergency Department areas are using the LIFEPAK 20e. The Adult ED will also use LIFEPAK 15 defibrillators to meet its clinical needs. Ambulatory off sites will be updated at a future date. For more information, email [email protected]. The change is part of a Yale New Haven Health System effort to standardize defibrillators/AEDs. The Saint Raphael Campus and YNHHS’ other hospitals were already using Stryker’s LIFEPAK for adult patients and ZOLL for neonatal and pediatric patients. 

Save the date: Nursing research conference is April 13

Nurses throughout Yale New Haven Health System are invited to the 15th annual Janet Parkosewich Nursing Research Conference. The conference will be held in-person, 8 am - 4 pm Thursday, April 13, at the Yale University West Campus Conference Center. The keynote speaker is Joyce J. Fitzpatrick, RN, PhD, the Elizabeth Brooks Ford Professor of Nursing, Frances Payne Bolton School of Nursing, and Distinguished University Professor, Case Western Reserve University. Watch for future communications about submitting abstracts and registering for the conference.

YNHHS delivery networks recognized for diabetes self-management education

The American Diabetes Association (ADA) recently re-awarded recognition to diabetes self-management education programs at Bridgeport, Greenwich, Yale New Haven and Yale New Haven Children’s hospitals. Recognized programs have knowledgeable health professionals who teach participants about the diabetes disease process, nutrition, physical activity, medications, monitoring and how to prevent, detect and treat diabetes complications. This education can help prevent complications and unnecessary hospital admissions.

Heart and Vascular Center at YNHH again named a Hypertrophic Cardiomyopathy Center of Excellence

The Heart and Vascular Center at Yale New Haven Hospital has once again been designated a Hypertrophic Cardiomyopathy Center of Excellence by the Hypertrophic Cardiomyopathy Association. YNHH is the only Connecticut hospital – and one of just 45 nationwide – to earn this recognition. Hypertrophic cardiomyopathy (HCM) is caused by a thickening of the heart muscle, which in some people can result in shortness of breath, chest pain or problems in the heart’s electrical system that can lead to abnormal heart rhythms. HCM Centers of Excellence provide comprehensive diagnostic, treatment, education and research programs.

YNHH’s HCM services include advanced imaging, testing and treatment; genetic profiling; and novel clinical trials. The HCM team treats patients at all ages and stages of the disease and includes physicians and staff specializing in adult and pediatric cardiology, cardiac surgery, electrophysiology and cardiac anesthesia, cardiac imaging, social work, nutrition and genetics.